Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide
7519 Inquiries
2381089-83-2
99%
shenzhen
WEIYA
5mg/10mg/15mg/20mg/30mg/40mg/50mg/60mg/100mg*10vials/box
Yes
2026-11-29
Tirzepatide,Retatrutide,Semaglutide,Melanotan,peptide,Selank
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionProduct Description
RetatrutideTriple agonist peptide | Activates GLP‑1/GIP/GCGR pathways | Suppresses appetite, regulates blood glucose and supports weight lossSpecification
Multiple strengths availableMultiple strengths are available: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg .Each vial contains 10g, 10 vials per box.Minimum order: 1 box.Packing & Delivery
Secure Packaging, Prompt DeliveryWe offer multiple shipping options, with both China domestic warehouse and 3 warehouses in the US, plus warehouses in Australia, Europe and Canada.
· Specialized line shipping from China: ①.around 2 weeks②.FedEx: 5–7 days delivery.· Shipment from local warehouse: ①approx. 5 days②.Next-day delivery: receive the product the very next day.
Our packaging is secure and well-sealed. We guarantee a prompt reply within 24 hours, shipment within 48 hours after order placement, full logistics tracking and one-on-one dedicated service, to ensure the products reach you safely and intact.
Certifications
Purity over 99%, supports third-party verification
After Sales Service
Pre-sales: Multiple preferential policies are available for bulk orders, with customized discounts offered.In-sales: We provide real-time updates on shipment status. If parcels encounter customs detention or compliance issues, reshipment or refund options are available to ease your worries.After-sales: We offer continuous technical guidance for product application together with long-term after-sales protection, so you can sell with confidence.Company Profile
Weifang Weiya Trading Co., Ltd.established in 2014 ,is a globally recognized benchmark provider of one-stop CRO/CDMO services specialized in peptides.With 12 years of dedicated expertise in peptide manufacturing, we stand at the forefront of the industry and rank among China’s premier peptide manufacturers. We focus on peptide R&D, production and custom research services. Our products cover cosmetics, pharmaceuticals and scientific research fields, supplying peptide materials ranging from milligram to kilogram scales for global clients.We operate a GMP factory equipped with cutting-edge precision instruments for production, purification, testing, lyophilization and efficacy evaluation, including HPLC, LC-MS, GC, elemental analyzers and large-scale semi-preparative DAC-HPLC systems. We deliver high-quality peptides along with professional test reports such as purity analysis and mass spectrometry identification.Supported by an experienced R&D and production team, alongside a responsive sales team, we provide premium-quality products and thoughtful, dedicated service to every client.We have 3 warehouses in the US, plus warehouses in Australia, Europe and Canada.
ECHEMI Editorial ReferenceRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.Basic Info-
Product Name:
Retatrutide
Other Name:Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
CAS No.:2381089-83-2
InChIKeys:MLOLQJNKXBNWFW-SAGGEDDASA-N
Molecular Weight:0
EC Number:200-001-8
Color/Form:White lyophilized
Categories:
Characteristics-
Water Solubility:
Soluble in water (5mg/ml).
Storage Conditions:-20°C
Critical Temperature & Pressure:-20°C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,Melanotan,peptide,Selank
-
Location:
Room 701, Unit 3, Building 7, Fanrong Zunfu, No.22 Mizhou East Road, Mizhou Subdistrict, Zhucheng City, Weifang City, Shandong Province, P.R.China
-
Payment Terms:
100% TT in advance
-
Average lead Time:
2 days
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
501-1000
-
Year of Establishment:
2026
Company Certificates-
CAG
-
TR60
-
TR10
-
TR30
-
KPV GHK
-
RT20
-
MOTS
-
RT10
-
-
Inquiry History7519 Inquiries
Country Product Purchase Quantity Date Posted
United States
Retatrutide
4 MT Nov 2, 2026
United Kingdom
Retatrutide
1 KG Nov 1, 2026
United Kingdom
Retatrutide
10 MT Nov 1, 2026
United Kingdom
Retatrutide
300 MG Oct 31, 2026
Canada
Retatrutide
20 MG Oct 31, 2026
South Korea
Retatrutide
1 G Oct 31, 2026
South Africa
Retatrutide
5 MT Oct 31, 2026
United States
Retatrutide
100 MT Oct 31, 2026
Poland
Retatrutide
1 BOU Oct 30, 2026
United States
Retatrutide
10 PCS Oct 30, 2026
Paraguay
Retatrutide
1000 PCS Oct 30, 2026
Nigeria
Retatrutide
30 G Oct 30, 2026
United Kingdom
retatrutide
300 MG Oct 30, 2026
United States
Retatrutide
10 G Oct 30, 2026
Germany
Retatrutide
1 G Oct 30, 2026
New Zealand
retatrutide
10 MG Oct 30, 2026
Thailand
retatrutide
10 MG Oct 30, 2026
United Kingdom
Retatrutide
500 G Oct 30, 2026
Spain
Retatrutide
100 G Oct 30, 2026
Brazil
Retatrutide
10 Oct 29, 2026 Post an enquiry for this product
More from this Seller
-
-
-
High purity factory direct ship Oxytocin Acetate good effect
/ 99%
$60-62/G FOB
-
-
-
-
High purity 99%peptide Melanotan Worry-free After-sales Service
/ 99%
$60-61/G FOB
-
-
-
-
High purity peptide Weight Loss factory direct shi GLP-1/GLP-2/GLP-3
/ 99%
$62-64/G FOB
-







